
Oliver Chow MD
Cardiovascular Surgery
Assistant Professor of Clinical Cardiothoracic Surgery - Weill Cornell Medical College Thoracic Surgery Attending
56-45 Main StFlushing, NY 11355
Overview of Dr. Chow
Dr. Oliver Chow is a thoracic surgeon in Flushing, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian Brooklyn Methodist Hospital, New York-Presbyterian Queens, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 7 years. He is one of 23 doctors at NewYork-Presbyterian Brooklyn Methodist Hospital and one of 27 doctors at New York-Presbyterian Queens who specialize in Thoracic Surgery. He has more than 30 publications and over 500 citings.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Thoracic Surgery - Independent, 2017 - 2019
- Beth Israel Deaconess Medical CenterResidency, Surgery, 2015 - 2017
- Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, 2013 - 2015
- Rutgers Health/New Jersey Medical SchoolResidency, Surgery, 2010 - 2013
- Icahn School of Medicine at Mount SinaiClass of 2010
Certifications & Licensure
- NY State Medical License 2019 - 2026
- MA State Medical License 2015 - 2025
- NJ State Medical License 2015 - 2021
- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Administrative Chief Research Fellow Memorial Sloan Kettering Cancer Center, 2014
- Golden Apple Nomination for Teaching UMDNJ-New Jersey Medical School, 2012-2013
- Critical Care Resident of the Year UMDNJ-New Jersey Medical School, 2012
- Join now to see all
Publications & Presentations
PubMed
- All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cel...Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Sebron Harrison, Benjamin Lee
European Journal of Cardio-Thoracic Surgery. 2025-03-04 - No down-side to starting durvalumab immediately after chemoradiation for unresectable stage III non-small cell lung cancer-some answers but more questions.Oliver S Chow, Nasser K Altorki
Journal of Thoracic Disease. 2025-02-28 - Is Moving Beyond Nodal Staging a Bridge Too Far?Oliver S Chow, Nasser K Altorki
The Annals of Thoracic Surgery. 2025-01-01
Journal Articles
- Transanal surgery for cT1 rectal cancer: Patient selection, technique, and outcomesChow OS, Smith JJ, Gollub MJ, Garcia-Aguilar J, Seminars in Colon and Rectal Surgery, 2015
- Can we predict response and/or resistance to neoadjuvant chemoradiotherapy in patients with rectal cancer?Chow OS, Smith JJ, Gollub MJ, Garcia-Aguilar J, Curr Colorectal Cancer Rep, 3/21/2014
Press Mentions
- Surgical Resection After Neoadjuvant Durvalumab and Radiation Is Feasible and Safe in Non-Small Cell Lung Cancer: Results from a Randomized TrialMay 17th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: